Pages that link to "Q28585033"
Jump to navigation
Jump to search
The following pages link to IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system (Q28585033):
Displaying 50 items.
- Interleukin 1 receptor-like 1 (Q21983262) (← links)
- Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket (Q24321867) (← links)
- High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure (Q24610732) (← links)
- IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G (Q24633495) (← links)
- The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1 (Q24651453) (← links)
- Cardiac biomarkers: new tools for heart failure management (Q26991726) (← links)
- Fibroblasts in fibrosis: novel roles and mediators (Q26998508) (← links)
- Transcriptomic biomarkers of cardiovascular disease (Q27001652) (← links)
- Hematopoietic progenitor cells are innate Th2 cytokine-producing cells (Q27021587) (← links)
- Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences (Q27021613) (← links)
- Recent advances in mechanisms and treatments of airway remodeling in asthma: a message from the bench side to the clinic (Q27023557) (← links)
- Right ventricular failure and pathobiology in patients with congenital heart disease - implications for long-term follow-up (Q27026319) (← links)
- State of the Art: Newer biomarkers in heart failure (Q27027899) (← links)
- Elevated levels of soluble ST2 protein in dengue virus infected patients (Q27485633) (← links)
- Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis (Q28069174) (← links)
- Ischemia and reperfusion related myocardial inflammation: A network of cells and mediators targeting the cardiomyocyte (Q28084618) (← links)
- Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial (Q28253329) (← links)
- Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction (Q28274593) (← links)
- ST2: a novel remodeling biomarker in acute and chronic heart failure (Q28280799) (← links)
- Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure (Q28294246) (← links)
- Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry (Q28395328) (← links)
- Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes (Q28573603) (← links)
- IL-33 reduces the development of atherosclerosis (Q28594104) (← links)
- Right Atrium Volume Index in Patients with Secondary Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease. (Q30385148) (← links)
- Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure. (Q30386714) (← links)
- Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists (Q30418533) (← links)
- Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling (Q30659130) (← links)
- The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? (Q33374001) (← links)
- Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis (Q33458347) (← links)
- Intramyocardial fibroblast myocyte communication (Q33586605) (← links)
- The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases (Q33593742) (← links)
- Biomarkers in acute myocardial infarction. (Q33596823) (← links)
- Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients. (Q33711545) (← links)
- IL-33 promotes DC development in BM culture by triggering GM-CSF production (Q33719228) (← links)
- Soluble ST2 plasma concentrations predict mortality in severe sepsis (Q33722112) (← links)
- IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects. (Q33740028) (← links)
- Effects of interleukin-33 on cardiac fibroblast gene expression and activity (Q33765909) (← links)
- A functional variant in ST2 gene is associated with risk of hypertension via interfering MiR-202-3p (Q33844678) (← links)
- Role of IL-33 and its receptor in T cell-mediated autoimmune diseases (Q33854499) (← links)
- Synovial fibroblasts promote the expression and granule accumulation of tryptase via interleukin-33 and its receptor ST-2 (IL1RL1) (Q33967423) (← links)
- Biomarker predictors of cardiac hospitalization in chronic heart failure: a recurrent event analysis (Q34080388) (← links)
- Interleukins in chronic liver disease: lessons learned from experimental mouse models (Q34154258) (← links)
- Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes (Q34300880) (← links)
- Up-regulated HMGB1 in EAM directly led to collagen deposition by a PKCβ/Erk1/2-dependent pathway: cardiac fibroblast/myofibroblast might be another source of HMGB1 (Q34336825) (← links)
- Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. (Q34358060) (← links)
- The interleukin-1 family: back to the future (Q34391415) (← links)
- The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure (Q34408467) (← links)
- Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes? (Q34462325) (← links)
- Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure (Q34472413) (← links)
- Modification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 gene (Q34576173) (← links)